Author

Emilie Yab

Centre National de la Recherche Scientifique

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Immunology· 1 Microbiology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Approach:experimental assay· 2 Organism:C. elegans· 1 Research Focus:drug response / drug discovery· 1 Research Focus:host-pathogen & immune response· 1 Assay:proteomics· 1 Organism:virus· 1

Frequent Co-Authors

Adrià SoguesiD· 1 shared Alexandra AubryiD· 1 shared Anne Marie WehenkeliD· 1 shared Antoine GedeoniD· 1 shared Ariel MéchalyiD· 1 shared Banujaa Jeyarajah· 1 shared Cyril PlanchaisiD· 1 shared Delphine PlanasiD· 1 shared

Activity by Year

2024-2026 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 24 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperMicrobiology

Adrià SoguesORCID

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

Assessing Corynebacterium glutamicum as a surrogate of Mycobacterium tuberculosis for DNA gyrase inhibitor design.

Yaëlle Wormser, Emilie Yab, Adrià Sogues, Francesca Gubellini, Estelle Capton, Estelle Lecat, Mathilde Ben Assaya, Alexandra Aubry, Ariel Méchaly, Pedro M. Alzari, Anne Marie Wehenkel, Antoine Gedeon, S. Petrella

This paper validates Corynebacterium glutamicum as a non-pathogenic surrogate for Mycobacterium tuberculosis to study DNA gyrase and discover new inhibitors.

bioRxiv · Jun 25, 2026 · PreprintMicrobiology

Escape of SARS-CoV-2 variants KP1.1, LB.1 and KP3.3 from approved monoclonal antibodies

Delphine Planas, Isabelle Staropoli, Cyril Planchais, Emilie Yab, Banujaa Jeyarajah, Yannis Rahou, Matthieu Prot, Florence Guivel‐Benhassine, Frederic Lemoine, Vincent Enouf, Etienne Simon‐Lorière, Hugo Mouquet, Marie‐Anne Rameix‐Welti, Olivier Schwartz

The paper evaluates the neutralization activity of two new monoclonal antibodies against emerging SARS-CoV-2 variants and finds reduced efficacy against some sublineages.

Pathogens and Immunity · Sep 30, 2024Peer-reviewedImmunology